CORMAX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cormax, and when can generic versions of Cormax launch?
Cormax is a drug marketed by Hikma and is included in one NDA.
The generic ingredient in CORMAX is clobetasol propionate. There are fourteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cormax
A generic version of CORMAX was approved as clobetasol propionate by COSETTE on February 16th, 1994.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CORMAX?
- What are the global sales for CORMAX?
- What is Average Wholesale Price for CORMAX?
Summary for CORMAX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 80 |
Patent Applications: | 4,476 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CORMAX at DailyMed |
![CORMAX drug patent expirations Drug patent expirations by year for CORMAX](/p/graph/s/t/CORMAX-patent-expirations.png)
US Patents and Regulatory Information for CORMAX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma | CORMAX | clobetasol propionate | CREAM;TOPICAL | 074220-001 | May 16, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |